Accelerated assessing of antisense RNA efficacy using a chimeric enhanced green fluorescent protein-antisense RNA-producing vector

Antisense Nucleic Acid Drug Dev. 2000 Oct;10(5):401-8. doi: 10.1089/oli.1.2000.10.401.

Abstract

The selection of suitable parts of a gene as antisense RNA sequences is largely a matter of trial and error and, as a consequence, a rather time-consuming process. In this study, we present a rapid and reproducible method to bypass this protracted procedure by using a chimeric enhanced green fluorescent protein (EGFP)-antisense RNA-producing vector. The combination of a reporter gene and antisense RNA allows easy measurement by flow cytometry of antisense RNA efficacy in successfully transfected cells shortly after transfection. Four chimeric EGFP-p185c-erbB-2-antisense RNA vectors were constructed and transfected into the p185-c-erbB-2-overexpressing cell line SKBR3. Within 1 week, we were able to estimate the inhibitory capacities of the different antisense RNA sequences used in this study. Our results strongly suggest that a chimeric EGFP-antisense RNA vector is an appropriate tool to expedite the laboratory work and time in screening the efficacy of antisense RNA strategies.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Division
  • Flow Cytometry
  • Gene Expression Regulation*
  • Genes, Reporter / genetics*
  • Genes, erbB-2 / genetics
  • Genetic Vectors / genetics*
  • Green Fluorescent Proteins
  • Humans
  • Luminescent Proteins / genetics*
  • Luminescent Proteins / metabolism
  • Microscopy, Fluorescence
  • RNA, Antisense / genetics*
  • RNA, Antisense / metabolism
  • Receptor, ErbB-2 / biosynthesis
  • Receptor, ErbB-2 / genetics
  • Reproducibility of Results
  • Time Factors
  • Transfection
  • Tumor Cells, Cultured

Substances

  • Luminescent Proteins
  • RNA, Antisense
  • Green Fluorescent Proteins
  • Receptor, ErbB-2